In addition, this assay might be valuable for diagnostics of other TDP-43 proteinopathies such as frontotemporal dementia, Alzheimer’s disease with TDP-43 pathology and limbic-predominant age-related TDP-43 encephalopathy, and future studies will explore this potential. This evidence concerns the gene TARDBP and early-onset autosomal dominant Alzheimer disease.